Sarah Brennan
- Hematology top 5%
- Multiple Myeloma Research and Treatments 2
- Oncology top 10%
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 2
-
- Hedgehog Signaling Pathway Studies 3
- Epigenetics and DNA Methylation 3
- Retinoids in leukemia and cellular processes 2
- Genomics, phytochemicals, and oxidative stress 1
-
- Immunotherapy and Immune Responses 2
- Immune Cell Function and Interaction 2
- Co-authors
- William MatsuiRichard J. JonesQiuju WangRichard F. AmbinderJames BarberCarol Ann HuffD. Neil WatkinsCraig D. Peacock
- Partner nations
- United StatesCanada
In The Last Decade
Sarah Brennan
12 papers receiving 785 citations
Peers
Comparison fields: 5 of 60
- Hematology 308
- Oncology 379
- Pathology and Forensic Medicine 143
- Genetics 78
- Molecular Biology 492
Countries citing papers authored by Sarah Brennan
This map shows the geographic impact of Sarah Brennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Brennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Brennan more than expected).
Fields of papers citing papers by Sarah Brennan
This network shows the impact of papers produced by Sarah Brennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Brennan. The network helps show where Sarah Brennan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah Brennan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 46 | |
| 2 | 2011 | 1 | |
| 3 | 2010 | 4 | |
| 4 | 2010 | 64 | |
| 5 | 2010 | 92 | |
| 6 | 2010 | 28 | |
| 7 | 2009 | 24 | |
| 8 | 2009 | 121 | |
| 9 | 2008 | 409 | |
| 10 | The novel telomerase inhibitor GRN163L targets drug-resistant cancer stem cells in multiple myeloma | 2007 | 1 |
| 11 | 2007 | 1 | |
| 12 | 2000 | 10 |
About Sarah Brennan
Sarah Brennan is a scholar working on Immunology, Hematology and Pharmaceutical Science, having authored 12 papers that have together received 801 indexed citations. Recurring topics across this work include Hedgehog Signaling Pathway Studies (3 papers), Epigenetics and DNA Methylation (3 papers), Retinoids in leukemia and cellular processes (2 papers), Immunotherapy and Immune Responses (2 papers), Multiple Myeloma Research and Treatments (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Immune Cell Function and Interaction (2 papers) and Genomics, phytochemicals, and oxidative stress (1 paper). The work is most often cited by research in Hematology (308 citations), Oncology (379 citations) and Pathology and Forensic Medicine (143 citations). Sarah Brennan has collaborated with scholars based in United States and Canada. Frequent co-authors include William Matsui, Richard J. Jones, Qiuju Wang, Richard F. Ambinder, James Barber, Carol Ann Huff, D. Neil Watkins, Craig D. Peacock, Ivan Borrello and B. Douglas Smith. Their work appears in journals such as Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.